Lysophosphatidylcholine: Potential Target for the Treatment of Chronic Pain

The bioactive lipid lysophosphatidylcholine (LPC), a major phospholipid component of oxidized low-density lipoprotein (Ox-LDL), originates from the cleavage of phosphatidylcholine by phospholipase A2 (PLA2) and is catabolized to other substances by different enzymatic pathways. LPC exerts pleiotropi...

Descripción completa

Detalles Bibliográficos
Autores principales: Ren, Jinxuan, Lin, Jiaqi, Yu, Lina, Yan, Min
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9368269/
https://www.ncbi.nlm.nih.gov/pubmed/35955410
http://dx.doi.org/10.3390/ijms23158274

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9368269/
https://www.ncbi.nlm.nih.gov/pubmed/35955410
http://dx.doi.org/10.3390/ijms23158274

Ejemplares similares